Development of decision-making considerations to support equitable patient selection in paediatric haemophilia trials
Artikel-Kategorie: Clinical Viewpoint
Online veröffentlicht: 08. Apr. 2022
Seitenbereich: 41 - 49
DOI: https://doi.org/10.2478/jhp-2022-0007
Schlüsselwörter
© 2022 Anne Fu, et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Decision-making matrix to support equitable potential participant selection – Assessment of medical need
1 | Efficacy of current intervention (potential unmet medical need) |
a | Presence of breakthrough bleeds in the last 12 months |
b | Frequency of infusion in the last 12 months |
c | Joint health and historical and/or current joints identified |
Decision-making matrix to support equitable potential participant selection – Assessment of potential need for support
2 | Potential need for support |
a | Challenges with transportation to site for care |
b | Difficulty managing intravenous infusions of factor independently |
c | Challenges with venous access in the home (home care) |
j_jhp-2022-0007_tab_004
Jansen et al. [ |
Investigational COVID-19 therapies |
‘First come, first served’ may not be equitable as patients with connections may learn about and join trials earlier Allocation method may be arrived at through stakeholder discussions |
Dobra et al. [ |
Investigational cystic fibrosis treatments |
Allocation method determined through group discussions and consultations |
Weijer [ |
N/A |
|
MacKay & Saylor [ |
N/A |
|
Emanuel et al. [ |
N/A |
Subjects should be selected to minimise risks and maximise benefits to individuals and to society |
Strassle [ |
Investigational cystic fibrosis treatments |
|
MacKay [ |
N/A |
|
Gupta & Morain [ |
COVID-19 vaccines |
Random lottery or ‘first come, first served’ is not recommended because this strategy is inequitable and unlikely to reduce morbidity, mortality, or health disparities |
Henn [ |
COVID-19 vaccines |
This order is based on the principle that “those who are most needed come first, followed by those most in need.” [ |
Rawlings et al. [ |
Scarce medical resources during the COVID-19 pandemic |
‘First come, first served’ is not advised as it prioritises those who can access resources quickly and makes no attempt to maximise benefits Developing a ‘clinical triage team’ to form an allocation framework may be advisable Decision-making should always consider the four fundamental principles of beneficence, non-maleficence, autonomy, and justice |
Guidolin et al. [ |
Medical resources, treatment, equipment, and staff during the COVID-19 pandemic |
Ethical criteria considered included the four pillars, [ Involving a multidisciplinary team was important in order to obtain a range of perspectives |
Decision-making matrix to support equitable potential participant selection – Participant safety considerations and identification of possible risk
3 | Safety considerations and possible barriers towards complying with care plan |
a | Family ability to infuse according to current treatment plan as measured by documentation of home care infusions |
b | Family ability to attend clinic review appointments as per the standard of care plan for haemophilia follow up |
c | Family ability to document home care infusions in patient diary as per standard of care for haemophilia |